
GLP-1 RA, Thiazolidinedione Combo Linked to Lower Mortality in Type 2 Diabetes
Combination therapy using a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and thiazolidinedione was linked to significantly lower risks of all-cause mortality, major cardiovascular events, and cardiovascular death in patients with type 2 diabetes ( …